Polycyclic aromatic hydrocarbons modulate cell proliferation in rat hepatic epithelial stem-like WB-F344 cells

Toxicology and Applied Pharmacology

Volumn 196, Issue 1, 2004, Pages 136-148

  Chramostová, Kateřina ^a   Vondráček, Jan ^a,b   Šindlerová, Lenka ^a   Vojtěšek, Bořivoj ^c   Kozubík, Alois ^a   Machala, Miroslav ^b  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b VETERINARY RESEARCH INSTITUTE   (Czech Republic)

^c MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Contact inhibition; Polycyclic aromatic hydrocarbons; Rat liver epithelial cells

Indexed keywords

5 METHYLCHRYSENE; ANTHRACENE; BENZ[A]ANTHRACENE; BENZO[A]PYRENE; BENZO[B]FLUORANTHENE; BENZO[GHI]PERYLENE; BENZO[J]FLUORANTHENE; BENZO[K]FLUORANTHENE; BENZO[RST]PENTAPHENE; CHRYSENE; CYTOCHROME P450; DIBENZ[A,H]ANTHRACENE; DIBENZO[A,E]PYRENE; DIBENZO[A,H]PYRENE; DIBENZO[A,L]PYRENE; FLUORANTHENE; FLUORENE; INDENO[1,2,3 CD]PYRENE; PHENANTHRENE; PIFITHRIN ALPHA; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN INHIBITOR; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; EPITHELIUM CELL; GENOTOXICITY; LIVER CELL; MUTAGENICITY; NONHUMAN; PROTEIN FUNCTION; RAT; STEM CELL; TREATMENT FAILURE;

ANIMALS; APOPTOSIS; CELL DIVISION; CELLS, CULTURED; CYTOCHROME P-450 CYP1A1; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; LIVER; MUTAGENS; POLYCYCLIC HYDROCARBONS, AROMATIC; RATS; RECEPTORS, ARYL HYDROCARBON; STEM CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1642413019     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.12.008     Document Type: Article

References (63)

1. Ayrton A.D., McFarlane M., Walker R., Neville S., Coombs M.M., Ioannides C. Induction of the P450I family of proteins by polycyclic aromatic hydrocarbons: possible relationship to their carcinogenicity. Toxicology. 60:1990;173-186.
2. Balint E.E., Vousden K.H. Activation and activities of the p53 tumour suppressor protein. Br. J. Cancer. 85:2001;1813-1823.
3. Binková B., Giguere Y., Rössner P. Jr., Dostál M., Šrám R.J. The effect of dibenzo[a,l]pyrene and benzo[a]pyrene on human diploid lung fibroblasts: the induction of DNA adducts, expression of p53 and p21(WAF1) proteins and cell cycle distribution. Mutat. Res. 471:2000;57-70.
4. Bláha L., Kapplová P., Vondráček J., Upham B., Machala M. Inhibition of gap-junctional intercellular communication by environmentally occurring polycyclic aromatic hydrocarbons. Toxicol. Sci. 65:2002;43-51.
5. Src. Environ. Toxicol. Pharmacol. 3:1997;211-220.
6. Callahan M.A., Slimak M.W., Gabel N.W., May I.P., Flower C.F., Freed J.R., Jennings P., DuPree R.I., Whitmore F.C., Maestri B., Mabey W.R., Holt B.R., Gould C. Water-related environmental fate of 129 priority pollutants. EPA-440/4-79-029a and b. 1979;US EPA, Springfield, VA.
7. 10 air particulate material using in vitro gene expression assays. Environ. Sci. Technol. 32:1998;1853-1860.
8. Culp S.J., Warbritton A.R., Smith B.A., Li E.E., Beland F.A. DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene. Carcinogenesis. 21:2000;1433-1440.
9. Dietrich C., Faust D., Budt S., Moskwa M., Kunz A., Bock K.W., Oesch F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: involvement of cyclin A. Toxicol. Appl. Pharmacol. 183:2002;117-126.
10. Dietrich C., Faust D., Moskwa M., Kunz A., Bock K.W., Oesch F. TCDD-dependent downregulation of gamma-catenin in rat liver epithelial cells (WB-F344). Int. J. Cancer. 103:2003;435-439.
11. Dipple A., Khan Q.A., Page J.E., Ponten I., Szeliga J. DNA reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens (review). Int. J. Oncol. 14:1999;103-111.
12. Durant J.L., Busby W.F. Jr., Lafleur A.L., Penman B.W., Crespi C.L. Human cell mutagenicity of oxygenated, nitrated and unsubstituted polycyclic aromatic hydrocarbons associated with urban aerosols. Mutat. Res. 371:1996;123-157.
13. Durant J.L., Lafleur A.L., Busby W.F. Jr., Donhoffner L.L., Penman B.W., Crespi C.L. Mutagenicity of C24H14 PAH in human cells expressing CYP1A1. Mutat. Res. 446:1999;1-14.
14. Fausto N. Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease. Semin. Liver Dis. 19:1999;243-252.
15. Fredersdorf S., Milne A.W., Hall P.A., Lu X. Characterization of a panel of novel anti-p21Waf1/Cip1 monoclonal antibodies and immunochemical analysis of p21Waf1/Cip1 expression in normal human tissues. Am. J. Pathol. 148:1996;825-835.
16. Gournay J., Auvigne I., Pichard V., Ligeza C., Bralet M.P., Ferry N. In vivo cell lineage analysis during chemical hepatocarcinogenesis in rats using retroviral-mediated gene transfer: evidence for dedifferentiation of mature hepatocytes. Lab. Invest. 82:2002;781-788.
17. Gu Y.Z., Hogenesch J.B., Bradfield C.A. The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40:2000;519-561.
18. Herrmann S., Seidelin M., Bisgaard H.C., Vang O. Indolo[3,2-b]carbazole inhibits gap junctional intercellular communication in rat primary hepatocytes and acts as a potential tumor promoter. Carcinogenesis. 23:2002;1861-1868.
19. Hodges N.J., Orton T.C., Strain A.J., Chipman J.K. Potentiation of epidermal growth factor-induced DNA synthesis in rat hepatocytes by phenobarbitone: possible involvement of oxidative stress and kinase activation. Carcinogenesis. 21:2000;2041-2047.
20. IARC Polynuclear Aromatic Compounds, Part 1: Chemical, Environmental and Experimental Data. 1983;IARC, Lyon.
21. Jones J.M., Anderson J.W., Tukey R.H. Using the metabolism of PAHs in s human cell line to characterize environmental samples. Environ. Toxicol. Pharmacol. 8:2000;119-126.
22. Kaufmann W.K., Behe C.I., Golubovskaya V.M., Byrd L.L., Albright C.D., Borchet K.M., Presnell S.C., Coleman W.B., Grisham J.W., Smith G.J. Aberrant cell cycle checkpoint function in transformed hepatocytes and WB-F344 hepatic epithelial stem-like cells. Carcinogenesis. 22:2001;1257-1269.
23. Khan Q.A., Dipple A., Anderson L.M. Protease inhibitor-induced stabilization of p21(waf1/cip1) and cell-cycle arrest in chemical carcinogen-exposed mammary and lung cells. Mol. Carcinog. 33:2002;1-8.
24. Klaunig J.E., Kamendulis L.M., Xu Y. Epigenetic mechanisms of chemical carcinogenesis. Hum. Exp. Toxicol. 19:2000;543-555.
25. Köhle C., Gschaidmeier H., Lauth D., Topell S., Zitzer H., Bock K.W. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-mediated membrane translocation of c-Src protein kinase in liver WB-F344 cells. Arch. Toxicol. 73:1999;152-158.
26. Komarov P.G., Komarova E.A., Kondratov R.V., Christov-Tselkov K., Coon J.S., Chernov M.V., Gudkov A.V. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science. 285:1999;1733-1737.
27. Kwon Y.W., Ueda S., Ueno M., Yodoi J., Masutani H. Mechanism of p53-dependent apoptosis induced by 3-methylcholanthrene: involvement of p53 phosphorylation and p38 MAPK. J. Biol. Chem. 277:2002;1837-1844.
28. Lane D.P., Stephen C.W., Midgley C.A., Sparks A., Hupp T.R., Daniels D.A., Greaves R., Reid A., Vojtěšek B., Picksley S.M. Epitope analysis of the murine p53 tumour suppressor protein. Oncogene. 12:1996;2461-2466.
29. Luch A., Kudla K., Seidel A., Doehmer J., Greim H., Baird W.M. The level of DNA modification by (+)-syn-(11S,12R,13S,14R)- and (-)- anti-(11R,12S,13S, 14R)-dihydrodiol epoxides of dibenzo[a,l]pyrene determined the effect on the proteins p53 and p21WAF1 in the human mammary carcinoma cell line MCF-7. Carcinogenesis. 20:1999;859-865.
30. Ma Q., Whitlock J.P. Jr. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol. Cell. Biol. 16:1996;2144-2150.
31. Machala M., Vondráček J., Bláha L., Ciganek M., Neča J. Aryl hydrocarbon receptor-mediated activity of mutagenic polycyclic aromatic hydrocarbons determined using in vitro reporter gene assay. Mutat. Res. 497:2001;49-62.
32. Mahadevan B., Luch A., Seidel A., Pelling J.C., Baird W.M. Effects of the (-)-anti-11R,12S-dihydrodiol 13S,14R-epoxide of dibenzo[a,l]pyrene on DNA adduct formation and cell cycle arrest in human diploid fibroblasts. Carcinogenesis. 22:2001;161-169.
33. Münzel P., Bock-Hennig B., Schieback S., Gschaidmeier H., Beck-Gschaidmeier S., Bock K.W. Growth modulation of hepatocytes and rat liver epithelial cells (WB-F344) by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Carcinogenesis. 17:1996;197-202.
34. Nakanishi Y., Pei X.H., Takayama K., Bai F., Izumi M., Kimotsuki K., Inoue K., Minami T., Wataya H., Hara N. Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21. Am. J. Respir. Cell Mol. Biol. 22:2000;747-754.
35. Nims R.W., Lubet R.A. Cytosol-mediated reduction of resorufin fluorescence: effects on the ethoxyresorufin O-deethylase (ETR) assay. Biochem. Pharmacol. 32:1983;175-176.
36. Oliver J.D., Roberts R.A. Receptor-mediated hepatocarcinogenesis: role of hepatocyte proliferation and apoptosis. Pharmacol. Toxicol. 91:2002;1-7.
37. Parrish A.R., Alejandro N.F., Bral C.M., Kevin Kerzee J., Bowes R.C., Ramos K.S. Characterization of glomerular cell phenotypes following repeated cycles of benzo[a]pyrene injury in vitro. Biochem. Pharmacol. 64:2002;31-39.
38. Patten Hitt E., DeLong M.J., Merrill A.H. Jr. Benzo(a)pyrene activates extracellular signal-related and p38 mitogen-activated protein kinases in HT29 colon adenocarcinoma cells: involvement in NAD(P)H:quinone reductase activity and cell proliferation. Toxicol. Appl. Pharmacol. 183:2002;160-167.
39. Piskorska-Pliszczynska J., Keys B., Safe S., Newman M.S. The cytosolic receptor binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons. Toxicol. Lett. 34:1986;67-74.
40. Prough R.A., Burke M.D., Mayer R.T. Direct fluorometric methods for measuring mixed function oxidase activity. Methods Enzymol. 52:1978;372-377.
41. Puga A., Barnes S.J., Chang C., Zhu H., Nephew K.P., Khan S.A., Shertzer H.G. Activation of transcription factors activator protein-1 and nuclear factor-kappaB by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Pharmacol. 59:2000;997-1005.
42. Puga A., Xia Y., Elferink C. Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem.-Biol. Interact. 141:2002;117.
43. Rodriguez L.V., Dunsford H.A., Steinberg M., Chaloupka K.K., Zhu L., Safe S., Womack J.E., Goldstein L.S. Carcinogenicity of benzo[a]pyrene and manufactured gas plant residues in infant mice. Carcinogenesis. 18:1997;127-135.
44. Rubin H. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis. 22:2001;1903-1930.
45. Rummel A.M., Trosko J.E., Wilson M.R., Upham B.L. Polycyclic aromatic hydrocarbons with bay-like regions inhibited gap junctional intercellular communication and stimulated MAPK activity. Toxicol. Sci. 49:1999;232-240.
46. Schmidt J.V., Bradfield C.A. Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12:1996;55-89.
47. Schrenk D., Eisenmann-Tappe I., Gebhardt R., Mayer D., el Mouelhi M., Rohrdanz E., Munzel P., Bock K.W. Drug metabolizing enzyme activities in rat liver epithelial cell lines, hepatocytes and bile duct cells. Biochem. Pharmacol. 41:1991;1751-1757.
48. Schwarz M., Buchmann A., Stinchcombe S., Kalkuhl A., Bock K. Ah receptor ligands and tumor promotion: survival of neoplastic cells. Toxicol. Lett. 112-113:2000;69-77.
49. Shimba S., Komiyama K., Moro I., Tezuka M. Overexpression of the aryl hydrocarbon receptor (AhR) accelerates the cell proliferation of A549 cells. J. Biochem. (Tokyo). 132:2002;795-802.
50. Sigal S.H., Brill S., Fiorino A.S., Reid L.M. The liver as a stem cell and lineage system. Am. J. Physiol. 263:1992;G139-G148.
51. Tan Z., Chang X., Puga A., Xia Y. Activation of mitogen-activated protein kinases (MAPKs) by aromatic hydrocarbons: role in the regulation of aryl hydrocarbon receptor (AHR) function. Biochem. Pharmacol. 64:2002;771-780.
52. 2+ and cell proliferation in primary human mammary epithelial cells. Carcinogenesis. 18:1997;1177-1182.
53. Till M., Riebniger D., Schmitz H.-J., Schrenk D. Potency of various polycyclic aromatic hydrocarbons inducers of CYP1A1 in rat hepatocyte cultures. Chem.-Biol. Interact. 117:1999;135-150.
54. Trosko J.E., Ruch R.J. Cell-cell communication in carcinogenesis. Front. Biosci. 3:1998;D208-D236.
55. Tsao M.S., Smith J.D., Nelson K.G., Grisham J.W. A diploid epithelial cell line from normal adult rat liver with phenotypic properties of 'oval' cells. Exp. Cell Res. 154:1984;38-52.
56. Vanden Heuvel J.P., Lucier G. Environmental toxicology of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans. Environ. Health Perspect. 100:1993;189-200.
57. Vindelov L.L. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and staining of nuclei. Virchows Arch. B: Cell. Pathol. 24:1977;227-242.
58. 1-S-phase transition by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells. Toxicol. Sci. 70:2002;193-201.
59. Vousden K.H. p53: death star. Cell. 103:2000;691-694.
60. Wang G.J., Cai L. Induction of cell-proliferation hormesis and cell-survival adaptive response in mouse hematopoietic cells by whole-body low-dose radiation. Toxicol. Sci. 53:2000;369-376.
61. Weis L.M., Rummel A.M., Masten S.J., Trosko J.E., Upham B.L. Bay or baylike regions of polycyclic aromatic hydrocarbons were potent inhibitors of gap junctional intercellular communication. Environ. Health Perspect. 106:1998;17-22.
62. WHO Selected Non-Heterocyclic Polycyclic Aromatic Hydrocarbons. 1998;WHO, Geneva.
63. Willett K.L., Gardinali P.R., Sericano J.L., Wade T.L., Safe S.H. Characterization of the H4IIE rat hepatoma cell bioassay for evaluation of environmental samples containing polynuclear aromatic hydrocarbons (PAHs). Arch. Environ. Contam. Toxicol. 32:1997;442-448.